Benitec Biopharma Inc. Banner Image

Benitec Biopharma Inc. has reached its limit for free report views

Work for Benitec Biopharma Inc.? Upgrade Your Profile and unlock all your annual reports.

Benitec Biopharma Inc.

  • Ticker BNTC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Benitec Biopharma Inc. Logo Image
  • 11-50 Employees
  • Based in Melbourne, Australia
Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference (RNAi) with gene therapy with a goal of providing sustained, long-lasting silencing of disease-causing genes from a single administration. Benitec is using its technology, called DNA-directed RNA interference (ddRNAi) to develop a pipeline of product candidates forMore the treatment of several chronic and life-threatening human diseases , including oculopharyngeal muscular dystrophy (OPMD) and hepatitis B.
Benitec Biopharma Inc.

Most Recent Annual Report

Benitec Biopharma Inc. MOST RECENT 2019 Annual Report

Report Locked. Benitec Biopharma Inc. has reached its limit for free report views.

Older/Archived Annual Reports